CU maintains bond ratings, announces 2010 financing plans

Cornell has announced that it will fund a new medical college facility as an investment in biomedical research, and it is taking advantage of historically near-low interest rates to rebalance its debt portfolio. (April 12, 2010)

ILR School, Cornell New York to confer on health care

The ILR School, Weill Cornell Medical College and several domestic and international organizations will confer on health care reform in New York City May 11-12. (April 5, 2010)

Study: E-prescribing cuts medication errors by seven-fold

A Cornell medical school study finds that when doctors use electronic systems to write prescriptions, they make seven times fewer errors than when they scrawl by hand. (March 30, 2010)

Big Red by the Bay panel explores how we make decisions

Six Cornell professors shed some light on the reality of social behavior during 'A Meeting of the Minds: Decoding Our Decisions' at the Big Red by the Bay event March 18 in San Francisco. (March 24, 2010)

Breakthrough may lead to abundant adult stem cells for bone marrow transplants

Researchers have discovered a way to grow copious amounts of adult stem cells that will likely revolutionize bone marrow transplants, organ regeneration, and therapies for organs. (March 8, 2010)

Pat Watson takes on new AAD responsibilities

Patricia Watson '83 has been named senior associate vice president of alumni affairs and development. Her new position will take effect immediately. (March 2, 2010)

WCMC-Q students receive $280,000 in research grants

The students will investigate 11 different topics through the grants, which are part of $1.7 million provided to research institutions in Qatar this year by the Qatar National Research Fund. (Feb. 24, 2010)

Miniature ultrasound device could revolutionize pain relief

The latest ultrasound device created by Cornell graduate student George K. Lewis could one day introduce a whole new level of home therapy for pain management. (Feb. 16, 2010)

Researchers can see drug activity in solitary molecule

Weill Cornell's Scott Blanchard has developed technology that can observe drug activity in a solitary molecule while in motion. The development may lead to newer, safer drug therapies. (Feb. 16, 2010)